Unique Therapy Approved for Multiple Myeloma

Bristol-Myers Squibb and AbbVie announced that the FDA has approved Empliciti (elotuzumab) injection for the treatment of multiple myeloma as combination therapy with Revlimid (lenalidomide) and dexamethasone in patients who have received 1-3 prior therapies.

Air Pollution Raises CVD Risks in Women With Diabetes

Long periods of exposure to air pollution - including dust and car exhaust - heightens cardiovascular risks for women with diabetes, according to a studyin the Journal of the American Heart Association.

Progesterone may not Help Prevent Repeat Miscarriage

Taking progesterone supplements in the first trimester of pregnancy may not improve pregnancy outcomes for women with a history of miscarriage, according to a report published in the New England Journal of Medicine.

Bifidobacterium breve of Little Benefit to Very Preterm Infants

Probiotics don't appear to protect very preterm infants from serious complications, such as necrotizing enterocolitis, sepsis, or death, according to a new study published in The Lancet.

New Treatment for Hemophilia A Now Available

Baxalta announced the launch of Adynovate (antihemophilic factor [recombinant], PEGylated), after receiving approval from the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes, and routine prophylaxis to reduce the frequency of bleeding episodes in patients with hemophilia A aged ≥12 years.

AAP: Guidance on Pediatric Peri-Op Anesthesia

Guidance relates to care team, resources committed to patient care, pediatric-specific techniques

Study: Basal Insulin Peglispro vs. Insulin Glargine for Glycemic Control

In T2DM, also tied to increased triglycerides, aminotransferases, and liver fat content

Drug-Induced Aseptic Meningitis Following Antibiotic Use

Case report describes 87-year-old with 3 episodes; decreasing interval between dose, symptoms

Neurotoxicity Seen With Acyclovir at Recommended Dose in Dialysis

Case report describes acyclovir-induced neurotoxicity in patient treated with recommended dose

C. Difficile Infection Tied to Higher Risk of Post-Op Mortality

Postoperative complications also increased in this patient population